Funding History

As Principal Investigator

“Validation of Canine Models for Human Breast Cancer”

Auburn University Office of Vice President for Research IGP

David J. Riese II, PI; Curtis Bird, COVAM, co-PI

01/01/11 – 12/31/12

$70,125 total direct costs (Riese lab direct costs = $35,062)


Regulation of ErbB4 Signaling by Neuregulin Isoforms” 

National Institutes of Health/National Cancer Institute

R01CA114209

David J. Riese II, PI;  Mark A. Lemmon, UPenn, subcontractor

08/01/06 – 07/31/12

$ 1,241,777 total costs (Riese lab direct costs = $607,980)


“Instructional Equipment Grant”

Purdue School of Pharmacy Program

David J. Riese II, PI

 06/01/10 – 12/31/10

$6,400 total costs


Instructional Equipment Grant

Purdue School of Pharmacy Program

David J. Riese II, PI

01/01/09 – 12/31/09

$4,000 total costs


Synthesis and Evaluation of Targeted Cancer Chemotherapeutic Nanotubes” 

Purdue School of Pharmacy Lilly Endowment Seed Grant

David J. Riese II, PI; Donald Bergstrom, co-PI

01/01/08 – 12/31/08

$75,000 total costs (Riese lab direct costs = $25,000)


Identification of a Potential Mechanism by Which Parkinson's Disease Patients Exhibit an Elevated Risk of Breast Cancer” 

Showalter Trust

David J. Riese II, PI;  Val J. Watts, co-PI

07/01/05 – 12/31/06

$ 62,500 total direct costs


Regulation of Prostate Tumor Cell Line Proliferation and Tumorigenicity by the ErbB4 Receptor Tyrosine Kinase” 

USAMRMC Prostate Cancer Research Program

DAMD17-02-1-0130/PC010077

David J. Riese II, PI

02/01/02 – 01/31/05

$ 225,000 total direct costs


Tumor Imaging Agents Directed Against ErbB2

National Institutes of Health/National Cancer Institute

R21CA089274

David J. Riese II, PI

07/01/01 – 06/30/04

$ 200,000 total direct costs

 

Functional Analysis of the ErbB4 Receptor Tyrosine Kinase

USAMRMC Breast Cancer Research Program

DAMD17-00-1-0415/BC990790

David J. Riese II, PI

07/01/00 – 06/30/04

$ 132,000 total direct costs


Functional Analysis of the ErbB4 Receptor Tyrosine Kinase

USAMRMC Breast Cancer Research Program

DAMD17-00-1-0416/BC990107

David J. Riese II, PI

07/01/00 – 06/30/03

$ 216,000 total direct costs

 

Inhibition of Breast Tumor Cell Line Proliferation, Motility, and Invasiveness

National Institutes of Health/National Cancer Institute

R21CA080770

David J. Riese II, PI

04/01/99 – 03/31/01

$ 150,000 total direct costs


Studies of the ErbB4 Receptor Tyrosine Kinase

Showalter Trust

David J. Riese II, PI

07/01/98 – 06/30/99

$ 45,200 total direct costs



As Co-investigator

“Graduate Assistance in the Areas of National Need (GAANN):

Fellowships in Biological and Pharmaceutical Engineering”

United States Department of Education

P200A120244

ME Byrne, AU Department of Chemical Engineering, PI

David J. Riese II, investigator/mentor

08/01/12 – 07/31/15

$ 824,532 total costs (funds are supporting a shared GRA)


"Cancer Center Support Grant"

National Institutes of Health/National Cancer Institute

P30CA023168

Timothy Ratliff, Purdue University, PI

David J. Riese II, et al., co-PIs

09/08/10 - 06/30/15

$ 6,407,190 total costs ($0 direct costs for Riese laboratory)

(This grant supports the Purdue University Center for 

Cancer Research; Dr. Riese is no longer affiliated with that 

organization.)


"LEAP Image Scanning Cytometer Shared Instrument"

National Institutes of Health

S10RR023651

James Leary, Purdue University, PI

David J. Riese II, et al., co-PIs

01/07/10 - 01/06/11

$ 495,000 total costs ($0 direct costs for Riese laboratory)


"Gefitinib-Sensitive EGF Receptor Mutants in Lung Cancer"

National Institutes of Health/National Cancer Institute

R01CA115830

Jeffrey Settleman, Massachusetts General Hospital, PI

David J. Riese II, co-PI

06/01/05 -  04/30/10

$ 200,000 total direct costs for the Riese laboratory


Targeted Molecular Probes for Tumor Imaging

National Institutes of Health/National Cancer Institute

R01CA094253

Henry VanBrocklin, Lawrence Berkeley National Laboratory, PI

David J. Riese II, co-PI

09/01/02 – 08/31/06

$ 240,000 total direct costs for the Riese laboratory


A Summer Undergraduate Training Program in Breast Cancer Research

USAMRMC Breast Cancer Research Program

DAMD17-02-1-0555/BC010171

G. Marc Loudon, Purdue University, PI

David J. Riese II, co-PI

05/01/02 – 04/30/06

$ 141,000 total direct costs ($0 directly for the Riese laboratory)


Binding determinants of Neuregulin to the ErbB4 receptor

National Institutes of Health/National Cancer Institute

F33CA085049

Robert P. Hammer, Louisiana State University, PI

David J. Riese II, mentor

03/15/00 – 03/14/01

$ 46,000 annual direct costs (stipend for Dr. Hammer)

 


Comments